Home › Glioma › Ohio › Columbus
Pag-aaral pangklinika para sa Glioma sa Columbus, OH
Isang pag-aaral para sa Glioma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Columbus. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Nagre-recruitPhase 1/2
- Nationwide Children's Hospital, Columbus
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Nagre-recruitPhase 2
- Ohio State University, Columbus
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
Nagre-recruitPhase 2
- Nationwide Children's Hospital, Columbus
Targeted Pediatric High-Grade Glioma Therapy
Nagre-recruitObservasyonal na pag-aaral
- Nationwide Children's Hospital, Columbus
Study of Olutasidenib and Temozolomide in HGG
Nagre-recruitPhase 2
- Nationwide Children's Hospital, Columbus
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
Nagre-recruitPhase 2
- Nationwide Children's Hospital, Columbus
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Nagre-recruitPhase 2
- The Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma
Nagre-recruit
- Ohio State University Medical Center, Columbus
Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
Nagre-recruitPhase 1/2
- Nationwide Children's Hospital, Columbus
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Nagre-recruitMaagang Phase 1Malugod na tinatanggap ang malusog na boluntaryo
- Nationwide Children's Hospital, Columbus
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Nagre-recruitPhase 2
- Nationwide Children's Hospital, Columbus
Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas
Nagre-recruitPhase 1
- Ohio State University Comprehensive Cancer Center, Columbus
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Nagre-recruitPhase 1/2
- Ohio State University Comprehensive Cancer Center, Columbus
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
Nagre-recruitMaagang Phase 1
- Nationwide Children's Hospital, Columbus
Phase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer Cells
Nagre-recruitPhase 1
- Nationwide Children's Hospital, Columbus
Pag-aaral para sa Glioma sa ibang lungsod
- New York City, NY25 pag-aaral
- Houston, TX23 pag-aaral
- Boston, MA20 pag-aaral
- Washington, DC19 pag-aaral
- Philadelphia, PA16 pag-aaral
- Miami, FL15 pag-aaral
- San Francisco, CA14 pag-aaral
- Chicago, IL13 pag-aaral
- Durham, NC12 pag-aaral
- Seattle, WA11 pag-aaral
- St. Louis, MO10 pag-aaral
- Aurora, CO10 pag-aaral
Iba pang pag-aaral sa Columbus
- Non-Small Cell Lung Cancer57 pag-aaral
- Kanser sa Suso40 pag-aaral
- Kanser sa Ovary39 pag-aaral
- Kanser (lahat ng uri)38 pag-aaral
- Kanser sa Baga37 pag-aaral
- Acute Myeloid Leukemia35 pag-aaral
- Chronic Lymphocytic Leukemia28 pag-aaral
- Metastatic Cancer27 pag-aaral
- Kanser ng Endometrium25 pag-aaral
- Kanser sa Prostate24 pag-aaral
- Multiple Myeloma24 pag-aaral
- Colorectal Cancer24 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.